Sandra Klein

Sandra Klein has a PhD from The University of Sheffield. Sandra has worked as a Clinical Research Coordinator and Postdoctoral Fellow at Icahn School of Medicine at Mount Sinai, focusing on disease modeling of cardiovascular disease. Sandra then moved on to work as a Clinical Research Coordinator at Columbia University Irving Medical Center, where Sandra was involved in industry-sponsored and investigator-initiated clinical trials for patients with hematologic malignancies. Currently, Sandra holds the position of Clinical Scientist, Associate Director at Constellation Pharmaceuticals, A MorphoSys Company, leading clinical trials for patients with hematologic malignancies.